Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Participants“
Suchtreffer
Begriffe & Kennungen
Arexvy · 4.8 · In a phase 3 open-label study (RSV OA=ADJ-025) that included participants 18 through 49 years of age (N = 1 02
Eintrag öffnenArexvy · 4.8 · In a phase 3 placebo-controlled study (RSV OA=ADJ-006), participants 60 years of age and older received either
Eintrag öffnenArexvy · 4.8 · In a phase 3 placebo-controlled study (RSV OA=ADJ-018) that included participants 50 through 59 years of age (
Eintrag öffnenBeyonttra · 4.8 · The safety data reflect exposure of 421 participants with ATTR-CM to acoramidis 712 mg (as two tablets of 356
Eintrag öffnenBosulif · 4.8 · Hepatobiliary disorders Of the 55 participants, the incidence based on laboratory data of ALT and AST increase
Eintrag öffnenComirnaty · 4.8 · 115 8.5 months after receiving Dose 3. Participants who received a booster (fourth dose) of Comirnaty Original
Eintrag öffnenComirnaty · 4.8 · 152 8.5 months after receiving Dose 3. Participants who received a booster (fourth dose) of Comirnaty Original
Eintrag öffnenComirnaty · 4.8 · 78 8.5 months after receiving Dose 3. Participants who received a booster (fourth dose) of Comirnaty Original/
Eintrag öffnenComirnaty · 4.8 · 9 8.5 months after receiving Dose 3. Participants who received a booster (fourth dose) of Comirnaty Original/O
Eintrag öffnenComirnaty · 4.8 · A subset from Study 2 Phase 2/3 participants of 825 adolescents 12 to 15 years of age who completed the origin
Eintrag öffnenComirnaty · 4.8 · A subset from Study 2 Phase 2/3 participants of 825 adolescents 12 to 15 years of age who completed the origin
Eintrag öffnenComirnaty · 4.8 · A subset from Study 2 Phase 2/3 participants of 825 adolescents 12 to 15 years of age who completed the origin
Eintrag öffnenComirnaty · 4.8 · A subset from Study 2 Phase 2/3 participants of 825 adolescents 12 to 15 years of age who completed the origin
Eintrag öffnenComirnaty · 4.8 · A subset from Study 2 Phase 2/3 participants of 825 adolescents 12 to 15 years of age who completed the origin
Eintrag öffnenComirnaty · 4.8 · Concomitant administration with seasonal influenza vaccine In Study 8, a Phase 3 study, participants 18 throug
Eintrag öffnenComirnaty · 4.8 · Concomitant administration with seasonal influenza vaccine In Study 8, a Phase 3 study, participants 18 throug
Eintrag öffnenComirnaty · 4.8 · Concomitant administration with seasonal influenza vaccine In Study 8, a Phase 3 study, participants 18 throug
Eintrag öffnenComirnaty · 4.8 · Concomitant administration with seasonal influenza vaccine In Study 8, a Phase 3 study, participants 18 throug
Eintrag öffnenComirnaty · 4.8 · Immunocompromised participants (adults and children) In study C4591024 (Study 10), a total of 124 immunocompro
Eintrag öffnenComirnaty · 4.8 · Immunocompromised participants (adults and children) In study C4591024 (Study 10), a total of 124 immunocompro
Eintrag öffnen